Poseida Therapeutics Inc. (PSTX): Price and Financial Metrics
PSTX Price/Volume Stats
| Current price | $9.50 | 52-week high | $9.67 |
| Prev. close | $9.56 | 52-week low | $1.87 |
| Day low | $9.49 | Volume | 21,420,600 |
| Day high | $9.67 | Avg. volume | 7,365,775 |
| 50-day MA | $6.52 | Dividend yield | N/A |
| 200-day MA | $3.79 | Market Cap | 928.85M |
PSTX Stock Price Chart Interactive Chart >
Poseida Therapeutics Inc. (PSTX) Company Bio
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
PSTX Price Returns
| 1-mo | 0.53% |
| 3-mo | 280.00% |
| 6-mo | 184.43% |
| 1-year | 244.20% |
| 3-year | 102.13% |
| 5-year | N/A |
| YTD | -1.04% |
| 2024 | 185.71% |
| 2023 | -36.60% |
| 2022 | -22.17% |
| 2021 | -37.92% |
| 2020 | N/A |
Loading social stream, please wait...